← Insider buys
SNDX

Syndax Pharmaceuticals, Inc. · Healthcare

Head of R&D, CMO Nicholas A.j. Botwood sold $1.2M of Syndax Pharmaceuticals, Inc.

Sold$1,183,643
$18.07Price
65,515Shares
−52%Stake

What SNDX did after the filing

Filed Jun 12Copier in Jun 15
The stock from Mon, Jun 15 open, $18.22
+5.5%
S&P 500, same days
−3.0%

Measured over 30 trading days, to the Jul 29 close.

Traded Thu, Jun 11. Filed Fri, Jun 12, 5:09 PM ET, after the close. Returns use the Jun 15 open and the Jul 29 close. Not investment advice.